Magnesium is the fourth most abundant mineral and the second most abundant intracellular
divalent cation and has been recognized as a cofactor for> 300 metabolic reactions in the …

Traditional dietary recommendations to renal patients limited the intake of fruits and
vegetables because of their high potassium content. However, this paradigm is rapidly …

Although previous studies in the general population showed that hypomagnesemia is a risk
for cardiovascular diseases (CVD), the impact of magnesium on the prognosis of patients on …

Magnesium is the most abundant intracellular divalent cation and essential for maintaining
normal cellular physiology and metabolism, acting as a cofactor of numerous enzymes …

Background Vascular calcification (VC) is prevalent in patients suffering from chronic kidney
disease. Factors promoting calcification include abnormalities in mineral metabolism …

Over the last decade, an increasing number of studies report a close relationship between
serum magnesium concentration and cardiovascular disease risk in the general population …

Background Low serum magnesium levels in patients with kidney disease have been linked
to increased mortality. This study investigated whether similar associations existed in …

Although magnesium has been shown to prevent vascular calcification in vitro, controlled in
vivo studies in uremic animal models are limited. To determine whether dietary magnesium …

Background Previous studies reported that magnesium deficiency was associated with
vascular calcifications, atherosclerosis and cardiovascular disease, which might play an …

Context Mechanisms mediating the cardiovascular and renal protection exerted by SGLT2
inhibitors are still partially unknown. We investigated whether dapagliflozin modulates …